Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
Cançado GGL, Couto CA, Terrabuio DRB, Cançado ELR, Villela-Nogueira CA, Ferraz MLG, Braga MH, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Guedes LV, Signorelli IV, Coral GP, Levy C, Bittencourt PL; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: de lima pace fh. Dig Dis Sci. 2023 Feb;68(2):514-520. doi: 10.1007/s10620-022-07654-x. Epub 2022 Aug 22. Dig Dis Sci. 2023. PMID: 35989386
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: de lima pace fh. Dig Dis Sci. 2022 Jul;67(7):3305-3312. doi: 10.1007/s10620-021-07122-y. Epub 2021 Jun 28. Dig Dis Sci. 2022. PMID: 34181166
Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.
de Souza GS, Vidigal FM, Chebli LA, da Rocha Ribeiro TC, Furtado MC, de Lima Pace FH, de Miranda Chaves LD, de Oliveira Zanini KA, Gaburri PD, de Azevedo Lucca F, Zanini A, Ribeiro LC, Chebli JM. de Souza GS, et al. Among authors: de lima pace fh. Med Sci Monit. 2013 Aug 30;19:716-22. doi: 10.12659/MSM.889196. Med Sci Monit. 2013. PMID: 23989915 Free PMC article. Clinical Trial.
Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.
Vidigal FM, de Souza GS, Chebli LA, da Rocha Ribeiro TC, Furtado MC, Castro AC, Pinto AL, do Valle Pinheiro B, de Lima Pace FH, Machado de Oliveira J, de Oliveira Zanini KA, Gaburri PD, Zanini A, Ribeiro LC, Chebli JM. Vidigal FM, et al. Among authors: de lima pace fh. Med Sci Monit. 2014 Nov 5;20:2165-70. doi: 10.12659/MSM.890975. Med Sci Monit. 2014. PMID: 25370731 Free PMC article. Clinical Trial.
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Garcia PG, Chebli LA, da Rocha Ribeiro TC, Gaburri PD, de Lima Pace FH, Barbosa KVBD, Costa LA, de Almeida Cruz W, de Assis IC, Moraes BRM, Zanini A, Chebli JMF. Garcia PG, et al. Among authors: de lima pace fh. Int J Colorectal Dis. 2018 Sep;33(9):1285-1294. doi: 10.1007/s00384-018-3105-8. Epub 2018 Jun 21. Int J Colorectal Dis. 2018. PMID: 29926235